Gene expression profiling of Ca2+-ATPase inhibitor DTBHQ and antigen-stimulated RBL-2H3 mast cells

Inflammation Research

Volumn 51, Issue 12, 2002, Pages 611-618

  Nakamura, R ^a   Ishida, S ^a   Ozawa, S ^a   Saito, Y ^a   Okunuki, H ^a   Teshima, R ^a   Sawada, J ^a  

^a NATIONAL INSTITUTE OF HEALTH SCIENCES   (Japan)

Author keywords

Antioxidant; DNA microarray; Gene expression; High affinity IgE receptor; Mast cell

Indexed keywords

2,5 DI TERT BUTYLHYDROQUINONE; ADENOSINE TRIPHOSPHATASE (CALCIUM); ADENOSINE TRIPHOSPHATASE INHIBITOR; ANTIGEN; ANTIOXIDANT; BOVINE SERUM ALBUMIN; COLONY STIMULATING FACTOR 1; FAS LIGAND; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 153; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 45; IMMUNOGLOBULIN E RECEPTOR; INTERLEUKIN 13; INTERLEUKIN 3; INTERLEUKIN 4; INTERLEUKIN 9; MONOCYTE CHEMOTACTIC PROTEIN 1; RELAXIN;

ANIMAL CELL; ARTICLE; CALCIUM CELL LEVEL; CALCIUM SIGNALING; CELL ACTIVATION; CONTROLLED STUDY; CROSS LINKING; DNA MICROARRAY; DRUG EFFECT; GENE; GENE EXPRESSION; GENE EXPRESSION REGULATION; IMMUNOSTIMULATION; MAST CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; ONCOGENE C JUN; RAT;

ANIMALS; ANTIOXIDANTS; APOPTOSIS; CALCIUM-TRANSPORTING ATPASES; CELL LINE; CYTOKINES; DOWN-REGULATION; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HYDROQUINONES; IMMUNOGLOBULIN E; MAST CELLS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RATS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC; UP-REGULATION;

EID: 12244277604     PISSN: 10233830     EISSN: None     Source Type: Journal    
DOI: 10.1007/PL00012436     Document Type: Article

References (48)

1. Wedemeyer J, Tsai M, Galli SJ. Roles of mast cells and basophils in innate and acquired immunity. Curr Opin Immunol 2000; 12: 624-31.
2. Eccleston E, Leonard BJ, Lowe JS, Welford HJ. Basophilic leukaemia in the albino rat and a demonstration of the basopoietin. Nat New Biol 1973; 244: 73-6.
3. Barsumian EL, Isersky C, Petrino MG, Siraganian RP. IgE-induced histamine release from rat basophilic leukemia cell lines: isolation of releasing and nonreleasing clones. Eur J Immunol 1981; 11: 317-23.
4. Seldin DC, Adelman S, Austen KF, Stevens RL, Hein A, Caulfield JP et al. Homology of the rat basophilic leukemia cell and the rat mucosal mast cell. Proc Natl Acad Sci USA 1985; 82: 3871-5.
5. 2+ influx, phospholipase activation, and histamine release in rat basophilic leukemia cells. Int Arch Allergy Appl Immunol 1985; 78: 92-100.
6. 2+ response of RBL-2H3 mast cells. Immunol Lett 2002; 80: 119-24.
7. Chen H, Centola M, Altschul SF, Metzger H. Characterization of gene expression in resting and activated mast cells. J Exp Med 1998; 188: 1657-68.
8. Lockhart DJ, Winzeler EA. Genomics, gene expression and DNA arrays. Nature 2000; 405: 827-36.
9. Cho RJ, Campbell MJ, Winzeler EA, Steinmetz L, Conway A, Wodicka L et al. A genome-wide transcriptional analysis of the mitotic cell cycle. Mol Cell 1998; 2: 65-73.
10. Ishida S, Huang E, Zuzan H, Spang R, Leone G, West M et al. Role of E2F in control of both DNA replication and mitotic functions as revealed from DNA microarray analysis. Mol Cell Biol 2001; 21: 4684-99.
11. Alizadeh AA, Eisen MB, Davis RE, Ma C, Lossos IS, Rosenwald A et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 2000; 403: 503-11.
12. Golub TR, Slonim DK, Tamayo P, Huard C, Gaasenbeek M, Mesirov JP et al. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science 1999; 286: 531-7.
13. West M, Blanchette C, Dressman H, Huang E, Ishida S, Spang R et al. Predicting the clinical status of human breast cancer by using gene expression profiles. Proc Natl Acad Sci USA 2001; 98: 11462-7.
14. Iida M, Tomita H, Nakajima T, Akasawa A, Yuyama-Ohtani N, Yoshida NL et al. Selective down-regulation of high-affinity IgE receptor (FcεRI) α-chain messenger RNA among transcriptome in cord blood-derived versus adult peripheral blood-derived cultured human mast cells. Blood 2001; 97: 1016-22.
15. Nakajima T, Matsumoto K, Suto H, Tanaka K, Ebisawa M, Tomita H et al. Gene expression screening of human mast cells and eosinophils using high-density oligonucleotide probe arrays: abundant expression of major basic protein in mast cells. Blood 2001; 98: 1127-34.
16. Dreskin SC, Metzger H. FcεRI-mediated hydrolysis of phosphoinositides in ghosts derived from rat basophilic leukemia cells. J Immunol 1991; 146: 3102-9.
17. Benhamou M, Stephan V, Robbins KC, Siraganian RP. High-affinity IgE receptor-mediated stimulation of rat basophilic leukemia (RBL-2H3) cells induces early and late protein-tyrosine phosphorylations. J Biol Chem 1992; 267: 7310-4.
18. Teshima R, Nakamura R, Furuno T, Nakanishi M. Degranulation in mast cells and basophils: Confocal and atomic force microscopy. Bioimages 1999; 7: 97-103.
19. 2+-ATPase inhibitors on the stimulation of mast cells. Recent Res Devel Immunology 2000; 2: 141-51.
20. 2+ response and leukotriene release in RBL-2H3 cells. Inflamm Res 1996; 45: 583-9.
21. 2+ signals in rat basophilic leukemia (RBL-2H3) cells. Biochim Biophys Acta 1994; 1221: 37-46.
22. 2+ ATPase inhibitors on MCP-1 release from bone marrow-derived mast cells and the involvement of p38 MAP kinase activation. Int Arch Allergy Immunol 2000; 121: 34-43.
23. 2+-ATPase inhibitor induces IL-4 and MCP-1 production in RBL-2H3 cells. Immunol Lett 1998; 64: 17-22.
24. Kaplan AP. Chemokines, chemokine receptors and allergy. Int Arch Allergy Immunol 2001; 124: 423-31.
25. Fornace AJ Jr, Alamo I Jr, Hollander MC. DNA damage-inducible transcripts in mammalian cells. Proc Natl Acad Sci USA 1988; 85: 8800-4.
26. Fornace AJ Jr, Nebert DW, Hollander MC, Luethy JD, Papathanasiou M, Fargnoli J et al. Mammalian genes coordinately regulated by growth arrest signals and DNA-damagin agents. Mol Cell Biol 1989; 9: 4196-203.
27. Plaut M, Pierce JH, Watson CJ, Hanley-Hyde J, Nordan RP, Paul WE. Mast cell lines produce lymphokines in response to cross-linkage of FcεRI or to calcium ionophores. Nature 1989; 339: 64-7.
28. Finkelman FD, Urban JF Jr. The other side of the coin: the protective role of the TH2 cytokines. Int Arch Allergy Immunol 2001; 107: 772-80.
29. Hsu SY, Nakabayashi K, Nishi S, Kumagai J, Kudo M, Sherwood OD et al. Activation of orphan receptors by the hormone relaxin. Science 2002; 295: 671-4.
30. Wang XW, Zhan Q, Coursen JD, Khan MA, Kontny HU, Yu L et al. GADD45 induction of a G2/M cell cycle checkpoint. Proc Natl Acad Sci USA 1999; 96: 3706-11.
31. Smith ML, Chen I-T, Zhan Q, Bae I, Chen C-Y, Gilmer TM et al. Interaction of the p53-regulated protein Gadd45 with proliferating cell nuclear antigen. Science 1994; 266: 1376-80.
32. Hollander MC, Sheikh MS, Bulavin DV, Lundgren K, Augeri-Henmueller L et al. Genomic instability in Gadd45a-deficient mice. Nat Genet 1999; 23: 176-84.
33. Takekawa M, Saito H. A family of stress-inducible GADD45-like proteins mediate activation of the stress-responsive MTK1/MEKK4 MAPKKK. Cell 1998; 95: 521-30.
34. Price BD, Calderwood SK. Gadd45 and Gadd153 messenger RNA levels are increased during hypoxia and after exposure of cells to agents which elevate the levels of the glucose-regulated proteins. Cancer Res 1992; 52: 3814-7.
35. Wagelie-Steffen AL, Hartmann K, Vliagoftis H, Metcalfe DD. Fas ligand (FasL, CD95L, APO-1L) expression in murine mast cells. Immunology 1998; 94: 569-74.
36. Hartmann K, Wagelie-Steffen AL, von Stebut E, Metcalfe DD. Fas (CD95, APO-1) antigen expression and function in murine mast cells. J Immunol 1997; 159: 4006-14.
37. INK4B is a potential effector of TGF-β-induced cell cycle arrest. Nature 1994; 371: 257-61.
38. Halazonetis TD, Georgopoulos K, Greenberg ME, Leder P. c-Jun dimerizes with itself and with c-Fos, forming complexes of different DNA binding affinities. Cell 1988; 55: 917-24.
39. Reyes H, Reisz-Porszasz S, Hankinson O. Identification of the Ah receptor nuclear translocator protein (Arnt) as a component of the DNA binding form of the Ah receptor. Science 1992; 259: 1193-5.
40. Brindle P, Linke S, Montminy M. Protein-kinase-A-dependent activator in transcription factor CREB reveals new role for CREM repressors. Nature 1993; 364: 821-4.
41. Nishiyama C, Yokota T, Okumura K, Ra C. The transcription factors Elf-1 and GATA-1 bind to cell-specific enhancer elements of human high-affinity IgE receptor α-chain gene. J Immunol 1999; 163: 623-30.
42. Yoshimura A, Ohkubo T, Kiguchi T, Jenkins NA, Gilbert DJ, Copeland NG et al. A novel cytokine-inducible gene CIS encodes an SH2-containing protein that binds to tyrosine-phosphorylated interleukin 3 and erythropoietin receptors. EMBO J 1995; 15: 2816-26.
43. Starr R, Willson TA, Viney EM, Murray LJ, Rayner JR, Jenkins BJ et al. A family of cytokine-inducible inhibitors of signalling. Nature 1995; 387: 917-21.
44. Berg SF, Dissen E, Westgaard IH, Fossum S. Molecular characterization of rat NKR-P2, a lectin-like receptor expressed by NK cells and resting T cells. Int Immunol 1998; 10: 379-85.
45. Wang Y, Lindstedt KA, Kovanen PT. Phagocytosis of mast cell granule remnant-bound LDL by smooth muscle cells of synthetic phenotype: a scavenger receptor-mediated process that effectively stimulates cytoplasmic cholesteryl ester synthesis. J Lipid Res 1996; 37: 2155-66.
46. Su ZZ, Shi Y, Fisher PB. Subtraction hybridization identifies a transformation progression-associated gene PEG-3 with sequence homology to a growth arrest and DNA damage-inducible gene. Proc Natl Acad Sci USA 1997; 94: 125-30.
47. Shinohara Y. Identification and characterization of hexokinase isozyme predominantly expressed in malignant tumor cells Yakugaku zasshi 2000; 120: 657-66.
48. Pastorino JG, Shulga N, Hoek JB. Mitochondrial binding of hexokinase II inhibits Bax induced cytochrome c release and apoptosis. J Biol Chem 2002; 277: 7610-8.